On April 22, 2022, XPhyto Therapeutics Corp. closed the transaction. The company issued 1,050,000 common shares at CAD 1 per share for total gross proceeds of CAD 1,050,000 in the final tranche.

The company paid CAD 84,000 and issued 84,000 share purchase warrants in finder's fees with respect to the final tranche.